Pathology of pancreatic ductal adenocarcinoma: Facts, challenges and future developments

doi:10.3748/wjg.v20.i38.13833

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 38

This Article

(395)

(368)

(0)

(13102)

(80)

Peer-Review Report of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Topic Highlight

World J Gastroenterol. Oct 14, 2014; 20(38): 13833-13841
Published online Oct 14, 2014. doi: 10.3748/wjg.v20.i38.13833

Table 2 Genetic syndromes that are associated with an elevated lifetime risk for the development of pancreatic ductal adenocarcinoma (adapted from [25])

Syndrome	Gene
Familial breast cancer	BRCA2
FAMMM syndrome	CDKN2A/p16
Lynch syndrome	MSH2, MLH1, others
Heriditary pancreatitis	PRSS1
Peutz-Jeghers syndrome	STK11
Ataxia teleangiectatica	ATM

Full Size Table

Citation: Esposito I, Konukiewitz B, Schlitter AM, Klöppel G. Pathology of pancreatic ductal adenocarcinoma: Facts, challenges and future developments. World J Gastroenterol 2014; 20(38): 13833-13841
URL: https://www.wjgnet.com/1007-9327/full/v20/i38/13833.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i38.13833

Esposito I, Konukiewitz B, Schlitter AM, Klöppel G. Pathology of pancreatic ductal adenocarcinoma: Facts, challenges and future developments. World J Gastroenterol 2014; 20(38): 13833-13841 [PMID: 25320520 DOI: 10.3748/wjg.v20.i38.13833]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.